CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma [Phase 2]
Summary
Phase 2 trial update for antineoplaston therapy in malignant mesothelioma has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Malignant Mesothelioma | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21